Martina Feitzinger is the Executive Vice President of Strategic Regulatory Affairs. Until 2006 she worked in Ebewe Pharma which later became Sandoz. Prior to joining Alvogen in the beginning of 2010, Martina served Actavis in various roles as Regulatory Strategy Manager WEMEA, Head of Portfolio and Regulatory Affairs AT & CH, responsible for the portfolio, launch management and the Regulatory Affairs teams.
Joining the Alvogen leadership team, Martina brings 14 years of experience and contacts in the generic industry into her position. Her main focus will be on the global regulatory affairs strategy for all filings and markets outside the US, to ensure an active and strong global position for Alvogen.